Belite Bio, Inc BLTE
NasdaqCM
$151.87-6.72 (-4.24%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Price reaction |
|---|---|---|---|---|---|
| Q2 2026 | 2026-08-12 | -0.70 | -0.73 | +4.1% | -6.4%$177.58→$166.28 |
| Q1 2026 | 2026-05-20 | -0.34 | -0.60 | +43.3% | +3.3%$139.70→$144.25 |
| Q4 2025 | 2026-03-02 | -0.38 | -0.56 | +32.1% | -11.8%$190.30→$167.88 |
| Q3 2025 | 2025-11-10 | -0.65 | -0.53 | -22.6% | -6.6%$113.19→$105.76 |
A dash means the current provider did not supply an actual value for that quarter. EPS actuals and estimates follow the provider's reporting basis and may differ from GAAP EPS in financial statements. The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.